Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prostate cancer treated with androgen deprivation therapy has consequences for bone.

Literature DB >> 24366636

Prostate cancer treated with androgen deprivation therapy has consequences for bone.

Robert A Adler¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 24366636 DOI： 10.1007/s12020-013-0113-x

Source DB: PubMed Journal: Endocrine ISSN： 1355-008X Impact factor: 3.633

× No keyword cloud information.

15 in total

1. Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer.

Authors: Matthew R Smith
Journal: Clin Cancer Res Date: 2007-01-01 Impact factor: 12.531

2. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.

Authors: Jan M Bruder; Jennie Z Ma; Joseph W Basler; Michelle D Welch
Journal: Urology Date: 2006-01 Impact factor: 2.649

Review 3. Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis.

Authors: Annie-Claude M Lassemillante; Suhail A R Doi; John D Hooper; John B Prins; Olivia R L Wright
Journal: Endocrine Date: 2013-10-31 Impact factor: 3.633

4. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.

Authors: Susan L Greenspan; Penelope Coates; Susan M Sereika; Joel B Nelson; Donald L Trump; Neil M Resnick
Journal: J Clin Endocrinol Metab Date: 2005-09-27 Impact factor: 5.958

Review 5. Management of osteoporosis in men on androgen deprivation therapy.

Authors: Robert A Adler
Journal: Maturitas Date: 2010-12-03 Impact factor: 4.342

6. Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer.

Authors: Philip J Saylor; Donald S Kaufman; M Dror Michaelson; Richard J Lee; Matthew R Smith
Journal: J Urol Date: 2010-06 Impact factor: 7.450

Review 7. Glucocorticoid-induced osteoporosis in men.

Authors: R A Adler; M C Hochberg
Journal: J Endocrinol Invest Date: 2011-05-27 Impact factor: 4.256

8. Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer.

Authors: Vivek K Wadhwa; Robin Weston; Nigel J Parr
Journal: BJU Int Date: 2010-10-15 Impact factor: 5.588